Article info

Download PDFPDF

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Authors

  1. { dahutw{at}mail.nih.gov
View Full Text

Citation

Karzai F, VanderWeele D, Madan RA, et al
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Publication history

  • Received July 23, 2018
  • Accepted November 23, 2018
  • First published December 4, 2018.
Online issue publication 
December 04, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.